INVIA, LLC appears in FDA device records as the applicant for 4DM, cleared under K260879 with a substantially equivalent decision dated September 10, 2026. The same company name is attached to Corridor4DM regulatory compliance records that list a 2010 market authorization, K101279, and a device listing number. The supplied filings describe software for viewing, processing and quantifying radiographic images, with radiology as the advisory committee specialty. [1][2][4]

The 4DM clearance and its stated scope

K260879 covers a device named 4DM, classified as an automated radiological image processing software product under regulation number 892.2050, Class II, product code QIH. The FDA record gives a decision date of September 10, 2026, a decision code of SESE with the description substantially equivalent, and a traditional clearance type with no third-party review. The submission was received March 17, 2026, and the applicant is listed as INVIA, LLC. [1]

The clearance letter identifies the trade name 4DM, regulation name Medical Image Management and Processing System, regulatory class II, and product codes QIH and LLZ. It names Corridor4DM K101279 as the predicate and Cvi42 K242781 as a reference for comparison, and states an intended use of software for viewing, processing, quantification and multidimensional review to aid in the interpretation of radiographic images. [2]

Corridor4DM and the published compliance record

INVIA's own regulatory compliance record for Corridor4DM names INVIA, LLC as manufacturer and Edward Ficaro as president, and identifies Corridor4DM as the product family name. The record lists market authorization 510(k) K101279, Class II classification, device listing number D206243 and establishment registration number 3004993756, with a date of August 9, 2010 and annual renewal as an ongoing requirement. [4]

A later version of the same compliance record carries the same manufacturer name, DUNS number and product family, and repeats the K101279 authorization, Class II classification, listing number and 2010 date. The record describes volumetric data from ECT and CT as a quality control for identifying structures where correlative spatial information is needed for diagnostic interpretation. [7]

Product description as published by INVIA

INVIA's 4DM software page describes 4DM as a suite used by medical professionals for non-invasive cardiovascular quantification, image review and reporting of SPECT, PET, hybrid CT and MFR patient studies. The page lists license tiers organized around MFR with hybrid CT, SPECT and PET combinations, and mentions a 60-day trial offer. These are the publisher's own product descriptions. [5]

The Corridor4DM user's guide carries a 2023 copyright held by INVIA, LLC and the Regents of the University of Michigan, and its symbol page gives an INVIA address in Ann Arbor, Michigan, with telephone and fax numbers and a unique device identifier string. The guide is a product document, not a statement of clinical performance. [6]

Regulatory documentation and filing snapshot

INVIA's regulatory page lists downloadable documents including ISO 13485:2016, MDSAP, MDR, MDD and MDD Directive 93/42/EEC certificates, a SOC 2 report, a Corridor4DM software bill of materials, a cybersecurity surveillance log, and instructions for use in several annual versions. The page presents these as links; the underlying certificates are not reproduced in the public documents. [8]

In the supplied filing snapshot as of November 20, 2026, the linked portfolio contains one 510(k) record, K260879, and the decision count for that full collection is one SESE. The explicitly smaller record sample also contains one entry, the same K260879 row. These counts describe the supplied filings only and are not measures of company sales, total portfolio or safety performance. [1]